Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Nothing like some 'leaks' on the FDA Resubmission

<< Previous

Bullboard Posts

Next >>

Comment by houbahopon Apr 27, 2023 5:44pm

71 Views

Post# 35418076

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Nothing like some 'leaks' on the FDA Resubmission

Even in a situation where votes % would be lower, it will be business as usual for TH.
I am sure they are prepared for such an event and have a plan to calm down the play.
They will press the lemon to the last drop.

I will be looking for the results.

I am pretty sure the big hands will vote in favor, out of fear of losing their dream.
And the BoD knows it.

Keep on dreamin'!

You will lose everything... eventually.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant